Shah A, Palmer AJR, Klein AA (2020) Strategies to minimize intraoperative blood loss during major surgery. Br J Surg. https://doi.org/10.1002/bjs.11393
Pabinger I, Fries D, Schöchl H, Streif W, Toller W (2017) Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. https://doi.org/10.1007/s00508-017-1194-y
Article PubMed PubMed Central Google Scholar
Delaney M et al (2016) Transfusion reactions: prevention, diagnosis, and treatment. Lancet. https://doi.org/10.1016/S0140-6736(15)01313-6
Clevenger B, Kelleher A (2014) Hazards of blood transfusion in adults and children. Contin Educ Anaesth Crit Care Pain. https://doi.org/10.1093/bjaceaccp/mkt042
Lang SA (2023) Outcomes of elective liver surgery worldwide: a global, prospective, multicenter, cross-sectional study. Int J Surg. https://doi.org/10.1097/JS9.0000000000000711
Bennett S et al (2017) The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB. https://doi.org/10.1016/j.hpb.2016.12.008
Koh A, Adiamah A, Gomez D, Sanyal S (2022) Safety and efficacy of tranexamic acid to minimise perioperative bleeding in hepatic surgery: a systematic review and meta-analysis. World J Surg. https://doi.org/10.1007/s00268-021-06355-2
Wellington K, Wagstaff AJ (2003) Tranexamic acid: a review of its use in the management of menorrhagia. Drugs. https://doi.org/10.2165/00003495-200363130-00008
Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs. https://doi.org/10.2165/00003495-199957060-00017
McCluskey SA et al (2006) Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl. https://doi.org/10.1002/lt.20868
Perel P, Ker K, Morales-Uribe CH, Roberts I (2013) Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010245.pub2
Article PubMed PubMed Central Google Scholar
Olldashi F et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet. https://doi.org/10.1016/S0140-6736(10)60835-5
Houston BL et al (2020) Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk for transfusion: a systematic review and meta-analysis. Transfus Med Rev. https://doi.org/10.1016/j.tmrv.2019.10.001
National Institute for Health and Care Excellence (2023) NICE guideline NG24-blood transfusion. NIHCE
National Institute for Health and Care Excellence (2020) 2020 Surveillance of blood transfusion (NICE guideline NG24). National Clinical Guideline Centre, no Appendices M-N. NIHCE
Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n71
Article PubMed PubMed Central Google Scholar
Higgins JPT et al (2019) Cochrane handbook for systematic reviews of interventions. Wiley. https://doi.org/10.1002/9781119536604
Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https://doi.org/10.1136/bmj.l4898
Article PubMed PubMed Central Google Scholar
Karanicolas PJ et al (2024) Tranexamic acid in patients undergoing liver resection the HeLiX randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2024.11783
Article PubMed PubMed Central Google Scholar
Wu CC et al (2006) Perioperative parenteral tranexamic acid in liver tumor resection: A prospective randomized trial toward ‘blood transfusion’-free hepatectomy. Ann Surg. https://doi.org/10.1097/01.sla.0000197561.70972.73
Article PubMed PubMed Central Google Scholar
Kaspar M, Ramsay MAE, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ (1997) Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg. https://doi.org/10.1097/00000539-199708000-00007
Boylan JF et al (1996) Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. https://doi.org/10.1097/00000542-199611000-00012
Dalmau A et al (2000) Tranexamic acid reduces red cell transfusion better than ε-aminocaproic acid or placebo in liver transplantation. Anesth Analg. https://doi.org/10.1213/00000539-200007000-00006
Karanicolas PJ et al (2016) Major liver resection, systemic fibrinolytic activity, and the impact of tranexamic acid. HPB. https://doi.org/10.1016/j.hpb.2016.09.005
Article PubMed PubMed Central Google Scholar
Teoh WY et al (2021) Prophylactic topical tranexamic acid versus placebo in surgical patients: a systematic review and meta-analysis. Ann Surg. https://doi.org/10.1097/SLA.0000000000003896
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009052.pub2
Article PubMed PubMed Central Google Scholar
Moggia E et al (2016) Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010683.pub3
Article PubMed PubMed Central Google Scholar
Yates J et al (2019) Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis. Transfusion. https://doi.org/10.1111/trf.15030
Sweetland S et al (2009) Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ (Online). https://doi.org/10.1136/bmj.b4583
Comments (0)